Cargando…

Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation

PURPOSE: We investigated the relationship between BRCA mutations, pathological findings, and magnetic resonance imaging (MRI) features in patients with breast cancer at risk for the mutation. METHODS: Genetic testing for BRCA mutations was performed in 275 breast cancer patients with at least one ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noh, Jae Myoung, Han, Boo-Kyung, Choi, Doo Ho, Rhee, Sun Jung, Cho, Eun Yoon, Huh, Seung Jae, Park, Won, Park, Hyojung, Nam, Seok Jin, Lee, Jeong Eon, Kil, Won-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800727/ https://www.ncbi.nlm.nih.gov/pubmed/24155760 http://dx.doi.org/10.4048/jbc.2013.16.3.308

Ejemplares similares

Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary
por: Noh, Jae Myoung, et al.
Publicado: (2012)

Exome sequencing in a breast cancer family without BRCA mutation
por: Noh, Jae Myoung, et al.
Publicado: (2015)

Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection
por: Noh, Jae Myoung, et al.
Publicado: (2014)

Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer
por: Kim, Haeyoung, et al.
Publicado: (2016)

Two Cases of Post-Radiation Sarcoma after Breast Cancer Treatment
por: Noh, Jae Myoung, et al.
Publicado: (2012)

Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast
por: Park, Jun Su, et al.
Publicado: (2015)

The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans
por: Kim, Hakyoung, et al.
Publicado: (2019)

Patterns of Recurrence after Breast-Conserving Treatment for Early Stage Breast Cancer by Molecular Subtype
por: Noh, Jae Myoung, et al.
Publicado: (2011)

Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer
por: Yu, Jeong Il, et al.
Publicado: (2015)

Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers
por: Lee, Young-Jae, et al.
Publicado: (2017)

Radiation Treatment in Pathologic N0-N1 Patients Treated with Neoadjuvant Chemotherapy Followed by Surgery for Locally Advanced Breast Cancer
por: Bae, Sun Hyun, et al.
Publicado: (2012)

Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer
por: Kim, Haeyoung, et al.
Publicado: (2013)

Germline BRCA Mutation and Clinical Outcomes in Breast Cancer Patients Focusing on Survival and Failure Patterns: A Long-Term Follow-Up Study of Koreans
por: Kim, Hakyoung, et al.
Publicado: (2020)

Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients
por: Kim, Haeyoung, et al.
Publicado: (2013)

Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes
por: Kim, Sang-Won, et al.
Publicado: (2016)

Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study
por: Son, Byung Ho, et al.
Publicado: (2012)

Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients
por: Kim, Hee Nam, et al.
Publicado: (2019)

Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2021)

Characteristics of BRCA2 Mutated Prostate Cancer at Presentation
por: Han, Hyunho, et al.
Publicado: (2022)

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients
por: Woo, Jinsun, et al.
Publicado: (2021)

Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube
por: Choi, Min Chul, et al.
Publicado: (2018)

Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review
por: Song, Won Hoon, et al.
Publicado: (2017)

Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer
por: Yang, Kyungmi, et al.
Publicado: (2020)

Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia
por: Koh, Hong, et al.
Publicado: (2018)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
por: Kim, Se Ik, et al.
Publicado: (2019)

Erratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube
por: Choi, Min Chul, et al.
Publicado: (2018)

Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
por: Eoh, Kyung Jin, et al.
Publicado: (2017)

The Effect of Reproductive Factors on Breast Cancer Presentation in Women Who Are BRCA Mutation Carrier
por: Kim, Ju-Yeon, et al.
Publicado: (2017)

Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2021)

Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy
por: Kil, Won Ho, et al.
Publicado: (2014)

Retraction note to: "Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy"
por: Kil, Won Ho, et al.
Publicado: (2015)

Reproductive factors as risk modifiers of breast cancer in BRCA mutation carriers and high-risk non-carriers
por: Park, Boyoung, et al.
Publicado: (2017)

Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls
por: Park, Ji Soo, et al.
Publicado: (2017)

Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience
por: Cassani, Chiara, et al.
Publicado: (2022)

Prevalence of BRCA1 and BRCA2 Mutations in Korean Breast Cancer Patients
por: Ahn, Sei Hyun, et al.
Publicado: (2004)

Author Correction: Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study
por: Kim, Joo Heung, et al.
Publicado: (2023)

Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06)
por: Noh, Jae Myoung, et al.
Publicado: (2014)

BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients
por: Park, Ji Hoon, et al.
Publicado: (2022)

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
por: Jung, Sung Mi, et al.
Publicado: (2020)

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
por: Bang, Yoon Ju, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4lvrq6rucv5ac3qvl6jo3mor6g